Describe the pathogenesis and natural history of HIV infection. Add a note on the opportunistic infections and tumours of AIDS.
The Virus
Human immunodeficiency virus is a retrovirus of the lentivirus family, causing progressive destruction of CD4 T lymphocytes and hence profound cell-mediated immunodeficiency.
- Single-stranded RNA with the enzymes reverse transcriptase, integrase and protease
- Envelope glycoproteins gp120 and gp41; core protein p24
- HIV-1 causes the world pandemic; HIV-2 is West African, less transmissible and slower
Transmission
| Route | Share | Notes |
|---|---|---|
| Sexual | Over 85% worldwide | Heterosexual transmission predominates in India; risk raised by ulcerative sexually transmitted disease |
| Parenteral | — | Injecting drug use, contaminated blood products, needlestick injury (risk about 0.3%) |
| Vertical | — | In utero, during delivery, or by breastfeeding; 25–40% without treatment, under 2% with antiretroviral therapy |
Pathogenesis
Gp120 binds the CD4 molecule — the primary receptor → A CO-receptor is also required: CCR5 (macrophage-tropic, early) or CXCR4 (T-cell-tropic, late) → gp41 mediates fusion; the virus enters → reverse transcriptase makes DNA from the viral RNA — error-prone, hence rapid mutation and drug resistance → integrase inserts the provirus into the host genome — the basis of latency and of the reservoir that cannot be eradicated → Activation of the cell triggers replication and CD4 cell death → Progressive CD4 depletion → failure of cell-mediated immunity
- CD4 cells are lost by several mechanisms — direct cytopathic effect, apoptosis of infected and uninfected cells, killing by cytotoxic T cells, and syncytium formation
- Macrophages and dendritic cells are relatively resistant and act as a reservoir, carrying the virus to lymphoid tissue and the brain
- Homozygous CCR5-delta32 deletion confers near-complete resistance to sexually acquired infection — the observation that made CCR5 a drug target
Natural History
| Stage | Duration | CD4 count | Features |
|---|---|---|---|
| Acute (seroconversion) illness | 3–6 weeks after exposure | Falls transiently | Glandular fever-like illness — fever, sore throat, rash, lymphadenopathy; very high viral load and highly infectious |
| Clinical latency | Median 8–10 years | Falls slowly, about 50–100 cells a year | Asymptomatic, but the virus replicates continuously in lymphoid tissue — latency is clinical, not virological |
| Symptomatic | Variable | 200–500 | Weight loss, oral candidiasis, herpes zoster, tuberculosis |
| AIDS | — | Below 200/mm3, or an AIDS-defining illness | Opportunistic infection and malignancy |
CLINICAL PEARL
"Latency" is a clinical description, not a biological one. Through the asymptomatic years the virus is replicating at enormous rates in lymphoid tissue and CD4 cells are being destroyed and replaced continuously. The count falls only when replacement can no longer keep pace — which is why treating early, before the lymphoid architecture is destroyed, gives much better outcomes.
Opportunistic Infections and Tumours
| CD4 count | Typical infections |
|---|---|
| Any count | Tuberculosis — the commonest opportunistic infection in INDIA, and the leading cause of death; bacterial pneumonia; herpes zoster |
| Below 200 | Pneumocystis jirovecii pneumonia, oesophageal candidiasis |
| Below 100 | Toxoplasma encephalitis, cryptococcal meningitis, cryptosporidiosis |
| Below 50 | Cytomegalovirus retinitis and colitis, Mycobacterium avium complex, primary CNS lymphoma |
- AIDS-defining tumours — KAPOSI sarcoma (caused by HHV-8), non-Hodgkin lymphoma (often EBV-driven), and invasive carcinoma of the cervix (HPV)
- Kaposi sarcoma is uncommon in India compared with Africa, because HHV-8 seroprevalence is low — a genuine regional difference
Morphology in AIDS
| Organ | Findings |
|---|---|
| Lymph nodes | Early — florid follicular hyperplasia with enlarged, irregular germinal centres. Late — follicular involution and complete "burnt-out" lymphoid depletion, so the node becomes small and fibrotic |
| Central nervous system | HIV encephalitis with microglial nodules and multinucleate giant cells; vacuolar myelopathy; progressive multifocal leucoencephalopathy (JC virus) |
| Lung | Pneumocystis pneumonia — foamy alveolar exudate with cysts shown by silver (GMS) staining |
| Gut | Cryptosporidial and CMV colitis; wasting and chronic diarrhoea |
| Skin and mucosa | Oral candidiasis and hairy leucoplakia (EBV); Kaposi sarcoma with spindle cells and slit-like vascular spaces |
- The lymph node changes summarise the whole disease — an initial vigorous response, then progressive exhaustion of the lymphoid system
Diagnosis and Applied Aspects
- Fourth-generation ELISA detects both antibody and p24 antigen, shortening the window period to about two to three weeks; confirmed by a second test on a different platform
- The window period is the interval before antibody is detectable, during which the patient is highly infectious and the test may be negative
- CD4 count guides prophylaxis and staging; viral load monitors treatment — the two answer different questions
- Antiretroviral therapy is now started at diagnosis regardless of CD4 count, and an undetectable viral load makes sexual transmission effectively impossible
- Immune reconstitution inflammatory syndrome — paradoxical worsening as immunity recovers and mounts a response to a latent infection, most often tuberculosis; it is not treatment failure
- Post-exposure prophylaxis within 72 hours after a needlestick injury, and pre-exposure prophylaxis for those at high risk
- Prevention of parent-to-child transmission is one of the most effective public health interventions available in India, reducing transmission from 30% to under 2%
- Co-trimoxazole prophylaxis is started when the CD4 count falls below 200, and prevents Pneumocystis and toxoplasmosis
- Every patient with tuberculosis should be offered an HIV test, and every patient with HIV screened for tuberculosis — the two are inseparable in Indian practice
- Antiretroviral drugs act at each step of the life cycle — entry inhibitors, reverse transcriptase inhibitors, integrase inhibitors and protease inhibitors; combination therapy is essential because the virus mutates so rapidly
- The virus cannot be eradicated because the integrated provirus persists in resting memory CD4 cells, which is why treatment is lifelong
- Universal precautions apply to every patient, not only to those known to be infected, since most transmission risk comes from undiagnosed infection
- Stigma and disclosure remain major barriers to care in India, and confidentiality is both an ethical and a legal obligation
- Tuberculosis in HIV is often atypical — sputum-negative, extrapulmonary, with normal or lower-zone chest radiographs and absent cavitation, because granulomas cannot form without CD4 cells
- Antiretroviral therapy has converted HIV into a chronic manageable disease, with near-normal life expectancy if treatment is started early and taken consistently
- Cardiovascular, renal and metabolic complications of long-term therapy and of chronic inflammation are now the dominant clinical problems
- India's national programme provides free antiretroviral therapy, and adherence support is as important as the drugs themselves
All questions in Immunopathology
- Q1Classify hypersensitivity reactions. Describe the mechanism of each type with examples. ★
- Q2Describe the aetiopathogenesis, autoantibodies and morphology of systemic lupus erythematosus. ★
- Q3Describe the pathogenesis and natural history of HIV infection. Add a note on the opportunistic infections and tumours of AIDS. ★
- Q4Describe the types and mechanisms of transplant rejection. Add a note on graft-versus-host disease. ★
- Q5Classify immunodeficiency disorders. Describe the important primary immunodeficiencies and the causes of secondary immunodeficiency. ★
- SN1Describe anaphylaxis with its causes, mechanism and management. ★
- SN2Describe the important autoantibodies with their disease associations. ★
- SN3Describe the HLA system with its classes and functions. Add a note on its disease associations. ★
- SN4Describe the pathogenesis and morphology of rheumatoid arthritis. ★
- SN5Describe immunological tolerance and the mechanisms by which it is lost. ★
- SN6Describe systemic sclerosis with its types, pathogenesis and organ involvement.
- SN7Describe graft-versus-host disease with its requirements, features and prevention.